Panganiban, Krizza Jan J.

HRN: 02-19-29  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2022
CEFUROXIME 1.5GM (VIAL)
07/31/2022
08/07/2022
IVT
1.5g
Q8
UTI
11/16/2022
CEFUROXIME 500MG (TAB)
11/16/2022
11/23/2022
PO
500mg
BID
MSAF
Waiting Final Action 
11/16/2022
METRONIDAZOLE 500MG (TAB)
11/16/2022
11/23/2022
PO
500mg
TID
MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: